PubRank

Jennifer L Wilkinson-Berka

Author PubWeight™ 26.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dysfunction of retinal neurons and glia during diabetes. Clin Exp Optom 2005 1.82
2 Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr Pharm Des 2007 1.45
3 Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension. Diabetes 2003 1.15
4 The renin-angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature. Prog Retin Eye Res 2010 1.15
5 Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin. Am J Pathol 2003 1.11
6 AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy. Glia 2008 1.04
7 Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol. Invest Ophthalmol Vis Sci 2007 1.00
8 The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy. Doc Ophthalmol 2009 1.00
9 Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity. J Comp Neurol 2007 1.00
10 The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies. Am J Pathol 2003 0.99
11 Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats. Nephrol Dial Transplant 2002 0.96
12 Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function. Diabetes 2010 0.94
13 Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity. J Comp Neurol 2010 0.92
14 The renin-angiotensin system and the developing retinal vasculature. Invest Ophthalmol Vis Sci 2005 0.92
15 Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies. J Cardiovasc Transl Res 2012 0.89
16 Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int 2002 0.86
17 Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: attenuation with renin-angiotensin blockade. Nephrology (Carlton) 2004 0.85
18 Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy. Nephron Physiol 2003 0.83
19 Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye. Invest Ophthalmol Vis Sci 2005 0.83
20 Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system. Clin Exp Pharmacol Physiol 2013 0.83
21 Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy. Hypertension 2012 0.82
22 Prorenin stimulates a pro-angiogenic and pro-inflammatory response in retinal endothelial cells and an M1 phenotype in retinal microglia. Clin Exp Pharmacol Physiol 2015 0.81
23 Regulation of angiotensin II receptors in the prostate of the transgenic (mRen-2)27 rat: effect of angiotensin-converting enzyme inhibition. Int J Biochem Cell Biol 2003 0.79
24 Lack of the antioxidant glutathione peroxidase-1 (GPx1) exacerbates retinopathy of prematurity in mice. Invest Ophthalmol Vis Sci 2013 0.79
25 The renin-angiotensin system and advanced glycation end-products in diabetic retinopathy: impacts and synergies. Curr Clin Pharmacol 2013 0.78
26 Cardiorenal protective effects of vasopeptidase inhibition with omapatrilat in hypertensive transgenic (mREN-2)27 rats. Clin Exp Hypertens 2004 0.77
27 Renin inhibition: new potential for an old therapeutic target. Hypertension 2005 0.75
28 Progressive diabetic nephropathy in the Ren-2 rat. Am J Physiol Renal Physiol 2007 0.75
29 Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 rats. J Am Soc Nephrol 2002 0.75